LEICA BIOSYSTEMS (DUBLIN) LIMITED

Leica Biosystems (Dublin) Limited is a long‑standing leader in anatomic pathology, drawing on more than 150 years of experience to tackle the challenges of modern diagnostics. From the production of high‑quality slides to cutting‑edge digital pathology platforms, the company supplies the full spectrum of tools required to prepare, stain and visualise tissue specimens, helping pathologists and researchers deliver accurate cancer diagnoses and improve patient outcomes.

The portfolio centres on three core areas: Histology solutions for primary staining and coverslipping – highlighted by the new HistoCore CHROMAX WS workstation, which boosts productivity and optimises reagent use; IHC and ISH staining instruments together with specialised reagents that consistently generate high‑quality slides; and Digital Pathology systems such as the Aperio GT 450 scanner, which provide DICOM‑compatible files, extended focus imaging and integrated quality‑control software. With a global network of over 3 000 experts, Leica Biosystems supports laboratories, hospitals and academic institutions in adopting connected, AI‑ready workflows.

Based in Dublin, the company combines proven performance with a collaborative approach, offering reliable equipment, comprehensive support and a vision of richer, more reassuring cancer diagnostics for patients worldwide.